| Ident. | Authors (with country if any) | Title |
|---|
| 000160 |
Anna A. Starshinova [Russie] ; Anna M. Malkova [Russie] ; Natalia Y. Basantsova [Russie] ; Yulia S. Zinchenko [Russie] ; Igor V. Kudryavtsev [Russie] ; Gennadiy A. Ershov [Russie] ; Lidia A. Soprun [Russie] ; Vera A. Mayevskaya [Russie] ; Leonid P. Churilov [Russie] ; Piotr K. Yablonskiy [Russie] | Sarcoidosis as an Autoimmune Disease |
| 000397 |
Andrei A. Deviatkin ; Yulia A. Vakulenko [Russie] ; Ludmila V. Akhmadishina ; Vadim V. Tarasov ; Marina I. Beloukhova ; Andrey A. Zamyatnin Jr. [Russie] ; Alexander N. Lukashev | Emerging Concepts and Challenges in Rheumatoid Arthritis Gene Therapy |
| 000440 |
Robert David Sandler [Royaume-Uni] ; Rachel Scarlett Tattersall [Royaume-Uni] ; Helene Schoemans [Belgique] ; Raffaella Greco [Italie] ; Manuela Badoglio [France] ; Myriam Labopin [France] ; Tobias Alexander [Allemagne] ; Kirill Kirgizov [Russie] ; Montserrat Rovira [Espagne] ; Muhammad Saif [Royaume-Uni] ; Riccardo Saccardi [Italie] ; Julio Delgado [Espagne] ; Zinaida Peric [Croatie] ; Christian Koenecke [Allemagne] ; Olaf Penack [Allemagne] ; Grzegorz Basak [Pologne] ; John Andrew Snowden [Royaume-Uni] | Diagnosis and Management of Secondary HLH/MAS Following HSCT and CAR-T Cell Therapy in Adults; A Review of the Literature and a Survey of Practice Within EBMT Centres on Behalf of the Autoimmune Diseases Working Party (ADWP) and Transplant Complications Working Party (TCWP) |
| 000472 |
Yehuda Shoenfeld [Israël, Russie] | Corona (COVID-19) time musings: Our involvement in COVID-19 pathogenesis, diagnosis, treatment and vaccine planning |
| 000485 |
Kim Lauper [Suisse] ; Denis Mongin [Suisse] ; Florenzo Iannone [Italie] ; Eirik K. Kristianslund [Norvège] ; Tore K. Kvien [Norvège] ; Dan C. Nordström [Finlande] ; Karel Pavelka [République tchèque] ; Manuel Pombo-Suarez [Espagne] ; Ziga Rotar [Slovénie] ; Maria J. Santos [Portugal] ; Catalin Codreanu [Roumanie] ; Galina Lukina [Russie] ; Sara L. Gale [États-Unis] ; Markus John [Suisse] ; Yves Luder [Suisse] ; Delphine S. Courvoisier [Suisse] ; Cem Gabay [Suisse] | Comparative effectiveness of TNF inhibitors and tocilizumab with and without conventional synthetic disease-modifying antirheumatic drugs in a pan-European observational cohort of bio-naïve patients with rheumatoid arthritis. |
| 000603 |
Anca Oana Docea [Roumanie] ; Aristidis Tsatsakis [Grèce, Russie, États-Unis] ; Dana Albulescu ; Oana Cristea [Roumanie] ; Ovidiu Zlatian [Roumanie] ; Marco Vinceti [Italie, États-Unis] ; Sterghios A. Moschos [Royaume-Uni] ; Dimitris Tsoukalas [Grèce] ; Marina Goumenou [Grèce] ; Nikolaos Drakoulis [Grèce] ; Josef M. Dumanov [États-Unis] ; Victor A. Tutelyan [Russie] ; Gennadii G. Onischenko [Russie] ; Michael Aschner [Russie, États-Unis] ; Demetrios A. Spandidos [Grèce] ; Daniela Calina [Roumanie] | A new threat from an old enemy: Re-emergence of coronavirus (Review) |
| 000624 |
Larisa Shelikhova [Russie] ; Maria Ilushina [Russie] ; Zhanna Shekhovtsova [Russie] ; Daria Shasheleva [Russie] ; Rimma Khismatullina [Russie] ; Elena Kurnikova [Russie] ; Dmitriy Pershin [Russie] ; Dmitriy Balashov [Russie] ; Svetlana Radygina [Russie] ; Pavel Trakhtman [Russie] ; Irina Kalinina [Russie] ; Yakov Muzalevskii [Russie] ; Alexei Kazachenok [Russie] ; Viktoria Zaharova [Russie] ; Varvara Brilliantova [Russie] ; Yulia Olshanskaya [Russie] ; Agnesa Panferova [Russie] ; Elena Zerkalenkova [Russie] ; Dina Baidildina [Russie] ; Galina Novichkova [Russie] ; Alexander Rumyantsev [Russie] ; Alexei Maschan [Russie] ; Michael Maschan [Russie] | αβ T Cell-Depleted Haploidentical Hematopoietic Stem Cell Transplantation without Antithymocyte Globulin in Children with Chemorefractory Acute Myelogenous Leukemia. |
| 000868 |
Gerd R. Burmester [Allemagne] ; Vibeke Strand [États-Unis] ; Andrea Rubbert-Roth [Suisse] ; Howard Amital [Israël] ; Tatiana Raskina [Russie] ; Antonio G Mez-Centeno [Espagne] ; Claudia Pena-Rossi [États-Unis] ; Leon Gervitz [États-Unis] ; Karthinathan Thangavelu [États-Unis] ; Gregory St John [États-Unis] ; Susan Boklage [États-Unis] ; Mark C. Genovese [États-Unis] | Safety and efficacy of switching from adalimumab to sarilumab in patients with rheumatoid arthritis in the ongoing MONARCH open-label extension |
| 000A31 |
Silvia Martina Ferrari [Italie] ; Poupak Fallahi [Italie] ; Giusy Elia [Italie] ; Francesca Ragusa [Italie] ; Stefania Camastra [Italie] ; Sabrina Rosaria Paparo [Italie] ; Claudia Giusti [Italie] ; Debora Gonnella [Italie] ; Ilaria Ruffilli [Italie] ; Yehuda Shoenfeld [Russie] ; Alessandro Antonelli [Italie] | Novel therapies for thyroid autoimmune diseases: An update. |
| 000A44 |
Manuela Pardeo [Italie] ; Jianmei Wang [Royaume-Uni] ; Nicolino Ruperto [Italie] ; Ekaterina Alexeeva [Russie] ; Vyacheslav Chasnyk [Russie] ; Rayfel Schneider [Canada] ; Gerd Horneff [Allemagne] ; Hans-Iko Huppertz [Allemagne] ; Kirsten Minden [Allemagne] ; Karen Onel [États-Unis] ; Lawrence Zemel [États-Unis] ; Alan Martin [États-Unis] ; Isabelle Koné-Paut [France] ; Antigoni Siamopoulou-Mavridou [Grèce] ; Clovis A. Silva [Brésil] ; Benjamin Porter-Brown [Royaume-Uni] ; Kamal N. Bharucha [États-Unis] ; Hermine I. Brunner [États-Unis] ; Fabrizio De Benedetti [Italie] | Neutropenia During Tocilizumab Treatment Is Not Associated with Infection Risk in Systemic or Polyarticular-course Juvenile Idiopathic Arthritis. |
| 000B12 |
Mark C. Genovese [États-Unis] ; Désirée Van Der Heijde [Pays-Bas] ; Yong Lin [États-Unis] ; Gregory St John [États-Unis] ; Sheldon Wang [États-Unis] ; Hubert Van Hoogstraten [États-Unis] ; Juan José G Mez-Reino [Espagne] ; Alan Kivitz [États-Unis] ; José Antonio Maldonado-Cocco [Argentine] ; Bruno Seriolo [Italie] ; Marina Stanislav [Russie] ; Gerd R. Burmester [Allemagne] | Long-term safety and efficacy of sarilumab plus methotrexate on disease activity, physical function and radiographic progression: 5 years of sarilumab plus methotrexate treatment |
| 000C54 |
L. A. Dykman [Russie] ; N. G. Khlebtsov [Russie] | Gold nanoparticles in chemo-, immuno-, and combined therapy: review [Invited] |
| 000C96 |
Ivan Foeldvari [Allemagne] ; Tamàs Constantin [Hongrie] ; Jelena Vojinovi [Serbie] ; Gerd Horneff [Allemagne] ; Vyacheslav Chasnyk [Russie] ; Joke Dehoorne [Belgique] ; Violeta Panaviene [Lituanie] ; Gordana Suši [Serbie] ; Valda Stanevicha [Lettonie] ; Katarzyna Kobusinska [Pologne] ; Zbigniew Zuber [Pologne] ; Bogna Dobrzyniecka [Pologne] ; Irina Nikishina [Russie] ; Brigitte Bader-Meunier [France] ; Luciana Breda [Italie] ; Pavla Doležalová [République tchèque] ; Chantal Job-Deslandre [France] ; Ingrida Rumba-Rozenfelde [Lettonie] ; Nico Wulffraat [Pays-Bas] ; Ronald D. Pedersen [États-Unis] ; Jack F. Bukowski [États-Unis] ; Bonnie Vlahos [États-Unis] ; Alberto Martini [Italie] ; Nicolino Ruperto [Italie] | Etanercept treatment for extended oligoarticular juvenile idiopathic arthritis, enthesitis-related arthritis, or psoriatic arthritis: 6-year efficacy and safety data from an open-label trial |
| 000D69 |
Gabriella Giancane [Italie] ; Valentina Muratore [Italie] ; Valentina Marzetti [Italie] ; Neus Quilis [Italie] ; Belen Serrano Benavente [Italie] ; Francesca Bagnasco [Italie] ; Alessandra Alongi [Italie] ; Adele Civino [Italie] ; Lorenzo Quartulli [Italie] ; Alessandro Consolaro [Italie] ; Angelo Ravelli [Italie, Russie] | Disease activity and damage in juvenile idiopathic arthritis: methotrexate era versus biologic era |
| 000E00 |
Surinder M. Soond [Russie] ; Maria V. Kozhevnikova ; Paul A. Townsend ; Andrey A. Zamyatnin [Russie] | Cysteine Cathepsin Protease Inhibition: An update on its Diagnostic, Prognostic and Therapeutic Potential in Cancer |
| 000E51 |
Olga V. Pashanova [Russie] ; Natalia B. Lopatina [Russie] ; Sergey A. Krivosheev [Russie] ; Natalia Y. Baranova [Russie] | Comparative Analysis of Approaches and Treatment Results of Patients with Early and Nonearly Rheumatoid Arthritis |
| 000E60 |
Alina Alshevskaya ; Julia Lopatnikova ; Julia Zhukova ; Oksana Chumasova ; Nadezhda Shkaruba ; Aleksey Sizikov ; Irina Evsegneeva ; Victor Gladkikh ; Aleksander Karaulov ; Sergey V. Sennikov [Russie] | Co-Expression Profile of TNF Membrane-Bound Receptors Type 1 and 2 in Rheumatoid Arthritis on Immunocompetent Cells Subsets |
| 001208 |
Maria Osminina [Russie] ; Nathalia Geppe [Russie] ; Elena Afonina [Russie] | Scleroderma "en coup de sabre" With Epilepsy and Uveitis Successfully Treated With Tocilizumab. |
| 001259 |
Joost Swart [Pays-Bas] ; Gabriella Giancane [Italie] ; Gerd Horneff [Allemagne] ; Bo Magnusson [Suède] ; Michael Hofer [Suisse] ; Katerina Alexeeva [Russie] ; Violeta Panaviene [Lituanie] ; Brigitte Bader-Meunier [France] ; Jordi Anton [Espagne] ; Susan Nielsen [Danemark] ; Fabrizio De Benedetti [Italie] ; Sylvia Kamphuis [Pays-Bas] ; Valda Sta Vi A ; Maria Tracahana [Grèce] ; Laura Marinela Ailioaie [Roumanie] ; Elena Tsitsami [Grèce] ; Ariane Klein [Allemagne] ; Kirsten Minden [Allemagne] ; Ivan Foeldvari [Allemagne] ; Johannes Peter Haas [Allemagne] ; Jens Klotsche [Allemagne] ; Anna Carin Horne [Suède] ; Alessandro Consolaro [Italie] ; Francesca Bovis [Italie] ; Francesca Bagnasco [Italie] ; Angela Pistorio [Italie] ; Alberto Martini [Italie] ; Nico Wulffraat [Pays-Bas] ; Nicolino Ruperto [Italie] | Pharmacovigilance in juvenile idiopathic arthritis patients treated with biologic or synthetic drugs: combined data of more than 15,000 patients from Pharmachild and national registries |
| 001299 |
Violetta Opoka-Winiarska [Pologne] ; Zbigniew Uber [Pologne] ; Ekaterina Alexeeva [Russie] ; Vyacheslav Chasnyk [Russie] ; Irina Nikishina [Russie] ; Gra Yna D Bowska [Pologne] ; El Bieta Smolewska [Pologne] | Long-term, interventional, open-label extension study evaluating the safety of tocilizumab treatment in patients with polyarticular-course juvenile idiopathic arthritis from Poland and Russia who completed the global, international CHERISH trial. |
| 001408 |
Grant S. Schulert [États-Unis] ; Francesca Minoia [Italie] ; John Bohnsack ; Randy Q. Cron ; Soah Hashad [Libye] ; Isabelle Koné-Paut [France] ; Mikhail Kostik [Russie] ; Daniel Lovell [États-Unis] ; Despoina Maritsi [Grèce] ; Peter A. Nigrovic [États-Unis] ; Priyankar Pal [Inde] ; Angelo Ravelli [Italie] ; Masaki Shimizu [Japon] ; Valda Stanevicha [Lettonie] ; Sebastiaan Vastert [Pays-Bas] ; Andreas Woerner [Suisse] ; Fabrizio De Benedetti [Italie] ; Alexei A. Grom [États-Unis] | Effect of Biologic Therapy on Clinical and Laboratory Features of Macrophage Activation Syndrome Associated With Systemic Juvenile Idiopathic Arthritis. |
| 001444 |
Kim Lauper [Suisse] ; Dan C. Nordström [Finlande] ; Karel Pavelka [République tchèque] ; Maria Victoria Hernández [Espagne] ; Tore K. Kvien [Norvège] ; Eirik Klami Kristianslund [Norvège] ; Maria Jose Santos [Portugal] ; Žiga Rotar [Slovénie] ; Florenzo Iannone [Italie] ; Catalin Codreanu [Roumanie] ; Galina Lukina [Russie] ; Sara L. Gale [États-Unis] ; Khaled Sarsour [États-Unis] ; Yves Luder [Suisse] ; Delphine Sophie Courvoisier [Suisse] ; Cem Gabay [Suisse] | Comparative effectiveness of tocilizumab versus TNF inhibitors as monotherapy or in combination with conventional synthetic disease-modifying antirheumatic drugs in patients with rheumatoid arthritis after the use of at least one biologic disease-modifying antirheumatic drug: analyses from the pan-European TOCERRA register collaboration. |
| 001445 |
Kim Lauper [Suisse] ; Denis Mongin [Suisse] ; Florenzo Iannone [Italie] ; Eirik Klami Kristianslund [Norvège] ; Tore K. Kvien [Norvège] ; Dan Nordström [Finlande] ; Karel Pavelka [République tchèque] ; Manuel Pombo-Suarez [Espagne] ; Ziga Rotar [Slovénie] ; Maria Jose Santos [Portugal] ; Catalin Codreanu [Roumanie] ; Galina Lukina [Russie] ; Delphine S. Courvoisier [Suisse] ; Cem Gabay [Suisse] | Comparative effectiveness of subcutaneous tocilizumab versus intravenous tocilizumab in a pan-European collaboration of registries. |
| 001455 |
Pavel I. Novikov [Russie] ; Ilya O. Smitienko [Russie] ; Maria V. Sokolova [Russie] ; Fatma Alibaz-Oner [Turquie] ; Sema Kaymaz-Tahra [Turquie] ; Haner Direskeneli [Turquie] ; Sergey V. Moiseev [Russie] | Certolizumab pegol in the treatment of Takayasu arteritis. |
| 001484 |
E L Nasonov [Russie] ; T V Popkova [Russie] | Atherosclerosis: perspectives of anti-inflammatory therapy. |
| 001562 |
Alan Kivitz [États-Unis] ; Lydie Baret-Cormel [France] ; Hubert Van Hoogstraten [États-Unis] ; Sheldon Wang [États-Unis] ; Janie Parrino [États-Unis] ; Christine Xu [États-Unis] ; Marina Stanislav [Russie] | Usability and Patient Preference Phase 3 Study of the Sarilumab Pen in Patients with Active Moderate-to-Severe Rheumatoid Arthritis |
| 001837 |
Josef S. Smolen [Autriche] ; Robert Landewé [Pays-Bas] ; Johannes Bijlsma [Pays-Bas] ; Gerd Burmester [Allemagne] ; Katerina Chatzidionysiou [Suède] ; Maxime Dougados [France] ; Jackie Nam [Royaume-Uni] ; Sofia Ramiro [Pays-Bas] ; Marieke Voshaar [Pays-Bas] ; Ronald Van Vollenhoven [Pays-Bas] ; Daniel Aletaha [Autriche] ; Martin Aringer [Allemagne] ; Maarten Boers [Pays-Bas] ; Chris D. Buckley [Royaume-Uni] ; Frank Buttgereit [Allemagne] ; Vivian Bykerk [États-Unis] ; Mario Cardiel [Mexique] ; Bernard Combe [France] ; Maurizio Cutolo [Italie] ; Yvonne Van Eijk-Hustings [Pays-Bas] ; Paul Emery [Pays-Bas] ; Axel Finckh [Suisse] ; Cem Gabay [Suisse] ; Juan Gomez-Reino [Espagne] ; Laure Gossec [France] ; Jacques-Eric Gottenberg [France] ; Johanna M W. Hazes [Pays-Bas] ; Tom Huizinga [Pays-Bas] ; Meghna Jani [Royaume-Uni] ; Dmitry Karateev [Russie] ; Marios Kouloumas [Suisse] ; Tore Kvien [Norvège] ; Zhanguo Li [République populaire de Chine] ; Xavier Mariette [France] ; Iain Mcinnes [Royaume-Uni] ; Eduardo Mysler [Argentine] ; Peter Nash [Australie] ; Karel Pavelka [République tchèque] ; Gyula Po R [Hongrie] ; Christophe Richez [France] ; Piet Van Riel [Pays-Bas] ; Andrea Rubbert-Roth [Allemagne] ; Kenneth Saag [États-Unis] ; Jose Da Silva [Portugal] ; Tanja Stamm [Autriche] ; Tsutomu Takeuchi [Japon] ; René Westhovens [Belgique] ; Maarten De Wit [Pays-Bas] ; Désirée Van Der Heijde [Pays-Bas] | EULAR recommendations for the management of rheumatoid arthritis with synthetic and biological disease-modifying antirheumatic drugs: 2016 update. |
| 001924 |
Riccardo Papa [Italie] ; Matteo Doglio [Italie] ; Helen J. Lachmann [Royaume-Uni] ; Seza Ozen [Turquie] ; Joost Frenkel [Pays-Bas] ; Anna Simon [Pays-Bas] ; Bénédicte Neven [France] ; Jasmin Kuemmerle-Deschner [Allemagne] ; Huri Ozgodan [Turquie] ; Roberta Caorsi [Italie] ; Silvia Federici [Italie] ; Martina Finetti [Italie] ; Maria Trachana [Grèce] ; Jurgen Brunner [Autriche] ; Liliana Bezrodnik [Argentine] ; Mari Carmen Pinedo Gago [Espagne] ; Maria Cristina Maggio [Italie] ; Elena Tsitsami [Grèce] ; Wafaa Al Suwairi ; Graciela Espada [Argentine] ; Anna Shcherbina [Russie] ; Guzide Aksu [Turquie] ; Nicolino Ruperto [Italie] ; Alberto Martini [Italie] ; Isabella Ceccherini [Italie] ; Marco Gattorno [Italie] | A web-based collection of genotype-phenotype associations in hereditary recurrent fevers from the Eurofever registry |
| 001949 |
T V Popkova [Russie] ; D S Novikova [Russie] ; E L Nasonov [Russie] | [Interleukin-6 inhibition and cardiovascular disease in patients with rheumatoid arthritis]. |
| 001998 |
Sergey Moiseev [Russie] ; Pavel Novikov [Russie] ; Victor Fomin [Russie] | Tocilizumab for polymyalgia rheumatica: a first or second line? |
| 001B95 |
Cem Gabay [Suisse] ; Myriam Riek [Suisse] ; Merete Lund Hetland [Danemark] ; Ellen-Margrethe Hauge [Danemark] ; Karel Pavelka [République tchèque] ; Matija Tomši [Slovénie] ; Helena Canhao ; Katerina Chatzidionysiou [Suède] ; Galina Lukina [Russie] ; Dan C. Nordström [Finlande] ; Elisabeth Lie [Norvège] ; Ioan Ancuta [Roumanie] ; M Victoria Hernández [Espagne] ; Piet L M C. Van Riel [Pays-Bas] ; Ronald Van Vollenhoven [Suède] ; Tore K. Kvien [Norvège] | Effectiveness of tocilizumab with and without synthetic disease-modifying antirheumatic drugs in rheumatoid arthritis: results from a European collaborative study. |
| 001E96 |
Mikhail M. Kostik [Russie] ; Margarita F. Dubko [Russie] ; Vera V. Masalova [Russie] ; Ludmila S. Snegireva [Russie] ; Tatyana L. Kornishina [Russie] ; Irina A. Chikova [Russie] ; Eugenia A. Isupova [Russie] ; Ekaterina M. Kuchinskaya [Russie] ; Natalia I. Glebova [Russie] ; Natalia V. Buchinskaya [Russie] ; Olga V. Kalashnikova [Russie] ; Vyacheslav G. Chasnyk [Russie] | Successful treatment with tocilizumab every 4 weeks of a low disease activity group who achieve a drug-free remission in patients with systemic-onset juvenile idiopathic arthritis. |
| 001F98 |
Irena Trbojevi Akma I [Croatie] ; Nicholas T. Ventham [Royaume-Uni] ; Evropi Theodoratou [Royaume-Uni] ; Frano Vu Kovi [Croatie] ; Nicholas A. Kennedy [Royaume-Uni] ; Jasminka Krišti [Croatie] ; Elaine R. Nimmo [Royaume-Uni] ; Rahul Kalla [Royaume-Uni] ; Hazel Drummond [Royaume-Uni] ; Jerko Štambuk [Croatie] ; Malcolm G. Dunlop [Royaume-Uni] ; Mislav Novokmet [Croatie] ; Yurii Aulchenko [Russie] ; Olga Gornik [Croatie] ; Harry Campbell [Royaume-Uni] ; Maja Pu I Bakovi [Croatie] ; Jack Satsangi [Royaume-Uni] ; Gordan Lauc [Croatie] | Inflammatory Bowel Disease Associates with Proinflammatory Potential of the Immunoglobulin G Glycome |
| 002381 |
V V Ryazhenov [Russie] ; S G Gorokhova [Russie] ; I V Emchenko [Russie] | Pharmacoeconomic Evaluation of Treatment With Tocilizumab in Russian Children With Systemic Juvenile Idiopathic Arthritis. |
| 002447 |
Hermine I. Brunner [États-Unis] ; Nicolino Ruperto [Italie] ; Zbigniew Zuber [Pologne] ; Caroline Keane [Royaume-Uni] ; Olivier Harari [Royaume-Uni] ; Andrew Kenwright [Royaume-Uni] ; Peng Lu [États-Unis] ; Ruben Cuttica [Argentine] ; Vladimir Keltsev [Russie] ; Ricardo M. Xavier [Brésil] ; Inmaculada Calvo [Espagne] ; Irina Nikishina [Russie] ; Nadina Rubio-Pérez [Mexique] ; Ekaterina Alexeeva [Russie] ; Vyacheslav Chasnyk [Russie] ; Gerd Horneff [Allemagne] ; Violetta Opoka-Winiarska [Pologne] ; Pierre Quartier [France] ; Clovis A. Silva [Brésil] ; Earl Silverman [Canada] ; Alberto Spindler [Argentine] ; Eileen Baildam [Royaume-Uni] ; M Luz Gámir [Espagne] ; Alan Martin [États-Unis] ; Christoph Rietschel [Allemagne] ; Daniel Siri [Argentine] ; Elzbieta Smolewska [Pologne] ; Daniel Lovell [États-Unis] ; Alberto Martini [Italie] ; Fabrizio De Benedetti [Italie] | Efficacy and safety of tocilizumab in patients with polyarticular-course juvenile idiopathic arthritis: results from a phase 3, randomised, double-blind withdrawal trial |
| 002893 |
P. I. Novikov [Russie] ; I. O. Smitienko [Russie] ; S. V. Moiseev [Russie] | Tumor necrosis factor alpha inhibitors in patients with Takayasu's arteritis refractory to standard immunosuppressive treatment: cases series and review of the literature |
| 002938 |
A. Kozlova [Russie] ; D. Konovalov [Russie] ; D. Abramov [Russie] ; A. Mitrofanova [Russie] ; A. Kislyakov [Russie] ; V. Roshchin [Russie] ; N. Miakova [Russie] ; I. Smirnova [Russie] ; E. Viktorova [Russie] ; A. Maschan [Russie] ; A. Shcherbina [Russie] | THU0447 Insufficient Efficacy of Tocilizumab Therapy in Children with Castleman’s Disease |
| 002992 |
E. Denisova [Russie] ; L. Katargina [Russie] ; A. Starikova [Russie] ; N. Lubimova [Russie] | THU0304 Efficacy of biologic therapies for pediatric rheumatic diseases associated uveitis |
| 002993 |
S. Valiyeva [Russie] ; E. Alexeeva [Russie] ; T. Bzarova [Russie] ; R. Denisova [Russie] ; K. Isayeva [Russie] ; T. Sleptsova [Russie] ; E. Mitenko [Russie] | THU0303 The efficacy and safety of ibandronic acid for intravenous administration for treatment of severe systemic osteoporosis in patients with juvenile arthritis |
| 002994 |
E. Alexeeva [Russie] ; R. Denisova [Russie] ; S. Valiyeva [Russie] ; T. Bzarova [Russie] ; K. Isayeva [Russie] ; T. Sleptsova [Russie] ; E. Mitenko [Russie] | THU0302 Safety and efficacy of tocilizumab therapy in children with systemic onset of juvenile idiopathic arthritis |
| 002A08 |
I. Guseva ; N. Demidova ; N. Soroka [Russie] ; E. Panasyuk ; E. Luchikhina ; E. Fedorenko ; E. Alexandrova ; A. Novikov ; D. Trofimov [Russie] ; D. Karateev ; E. Nasonov | THU0164 Polymorphism of Cytotoxic T-Lymphocyte Antigen 4 +49A/G is Associated with Refractoriness to Non-Biological Dmards in Rheumatoid Arthritis Patients |
| 002A13 |
G. Imametdinova ; E. Igolkina ; N. Chichasova ; E. Nasonov [Russie] ; S. Glukhova [Russie] | THU0156 The Evaluation of Joint Damage Progression in Patients with Rheumatoid Arthritis with Long-Term and Short-Term Remission |
| 002A16 |
I. Shirinsky [Russie] ; N. Kalinovskaya [Russie] ; O. Polovnikova [Russie] ; V. Shirinsky [Russie] | THU0142 Fenofibrate reduces inflammation but has no effect on endothelial progenitor cells in patients with rheumatoid arthritis |
| 002A31 |
A. Novikov ; E. N. Alexandrova ; A. N. Gerasimov [Russie] ; A. S. Avdeeva ; G. V. Lukina ; Y. A. Sigidin ; T. V. Popkova ; E. Y. Panasyuk ; E. L. Nasonov | THU0122 Multi-Biomarker Scores as Predictors of Response to Biologic Therapies in Rheumatoid Arthritis |
| 002A95 |
R. Osipyants [Russie] ; D. Karateev [Russie] ; E. Panasyuk [Russie] ; A. Smirnov [Russie] ; G. Lukina [Russie] ; S. Glukhova [Russie] ; E. Alexandrova [Russie] ; A. Volkov [Russie] ; E. Nasonov [Russie] | SAT0514 Associations between Functional Status and Ultrasound – Detected Synovitis and Joint Damage in Rheumatoid Arthritis during Tocilizumab Treatment |
| 002A96 |
R. Osipyants [Russie] ; D. Karateev [Russie] ; E. Panasyuk [Russie] ; A. Smirnov [Russie] ; G. Lukina [Russie] ; S. Glukhova [Russie] ; E. Alexandrova [Russie] ; A. Volkov [Russie] ; E. Nasonov [Russie] | SAT0513 Imaging Rather than Clinical Inflammation is Associated with Radiographic Progression in Tocilizumab-Treated Rheumatoid Arthritis Patients |
| 002B10 |
M. M. Kostik ; L. A. Scheplyagina [Russie] ; V. I. Larionova [Russie] | SAT0476 The Role of Vitamin D Receptor Gene Polymorphism (VDR) in Pathogenesis of Juvenile Idiopathic Arthritis and Bone Metabolism Disturbances. |
| 002B23 |
E. Alekseeva [Russie] ; R. Denisova ; S. Valieva ; T. Bzarova ; K. Isayeva ; T. Sleptsova ; E. Mitenko ; E. Chistyakova [Russie] ; A. Fetisova | SAT0459 Tocilizumab Therapy in Children with Systemic Juvenile Idiopathic Arthritis. Russian Experience |
| 002B25 |
E. Alekseeva [Russie] ; R. Denisova [Russie] ; S. Valieva [Russie] ; T. Bzarova [Russie] ; K. Isayeva [Russie] ; T. Sleptsova [Russie] ; E. Mitenko [Russie] ; E. Chistyakova [Russie] ; A. Fetisova [Russie] | SAT0458 Rituximab in the Treatment of Children with Systemic Lupus Erythematosus: Analysis of 12 Patients. |
| 002B26 |
E. Alekseeva [Russie] ; T. Bzarova ; A. Fetisova ; S. Valieva ; K. Isayeva ; R. Denisova ; T. Sleptsova ; E. Mitenko ; E. Chistyakova [Russie] | SAT0457 Efficacy and Safety of Etanercept in Combination with Methotrexate in the Patients with Early and Late Juvenile Idiopathic Arthritis |
| 002B29 |
R. Denisova ; E. Alekseeva [Russie] ; S. Valieva ; T. Bzarova ; K. Isayeva ; T. Sleptsova ; E. Mitenko ; E. Chistyakova [Russie] ; A. Fetisova | SAT0445 Survival of Tocilizumab Therapy in Children with Systemic Juvenile Idiopathic Arthritis. Russian Experience |
| 002B90 |
T. V. Popkova ; D. R. Olisaeva [Russie] ; O. A. Fomicheva [Russie] ; D. S. Novikova ; E. V. Gerasimova ; Y. A. Karpov [Russie] ; E. L. Nasonov | SAT0091 Invasive and Noninvasive Methods for Atherosclerosis Assessment in RA |
| 002B91 |
T. A. Lisitsyna ; D. Veltishchev ; O. Seravina ; O. Kovalevskaya ; A. Zeltyn ; V. Krasnov ; E. Nasonov [Russie] | SAT0090 Depression Recovery Improves the Efficacy of Rheumatoid Arthritis Treatment |
| 002C83 |
A. Volkov [Russie] ; R. Osipyants [Russie] ; E. Panasyuk [Russie] ; A. Smirnov [Russie] ; G. Lukina [Russie] ; S. Gluchova [Russie] ; E. Aleksandrova [Russie] ; D. Karateev [Russie] ; E. Nasonov [Russie] | OP0232 Monitoring anti-interleukin 6 receptor antibody treatment in rheumatoid arthritis and prediction progressive structural damage of the wrist joints by ultrasonography |
| 002E13 |
G. Burmester [Allemagne] ; T. Takeuchi [Japon] ; O. Barbarash [Russie] ; G. Ranganna [Royaume-Uni] ; D. Close [Royaume-Uni] ; A. Godwood [Royaume-Uni] ; D. Saurigny [Royaume-Uni] | FRI0232 Consistent efficacy and safety outcomes between european and japanese subjects with rheumatoid arthritis following treatment with mavrilimumab in the phase 2 earth study |
| 002E59 |
E. Pogozheva ; V. Amirdzhanova ; S. Makarov [Russie] | FRI0184 Postoperative complications in rheumatoid arthritis patients receiving biologic and nonbiologic disease-modifying antirheumatic drugs |
| 002F85 |
I. Nikishina [Russie] ; M. Kaleda [Russie] ; O. Kostareva [Russie] ; S. Rodionovskaya [Russie] | AB1161 Predictable and unexpected effects of tocilizumab in patients with systemic juvenile idiopathic arthritis |
| 002F90 |
L. Myasoutova [Russie] ; A. Vasiliev [Russie] ; S. Lapshina [Russie] | AB0805 Educational programs for patients with osteoporosis in clinical practice. |
| 002F91 |
L. Myasoutova [Russie] ; A. Vasiliev [Russie] ; S. Lapshina [Russie] | AB0804 Experience of educational programs for physicians in diagnosis and treatment of osteoporosis in kazan (russia) |
| 003011 |
R. G. Goloeva ; Z. Alekberova ; V. Tankovskyi [Russie] ; I. Guseva | AB0772 Ocular manifestations of behcet’s disease |
| 003052 |
S. Rodionovskaya [Russie] ; I. Nikishina [Russie] | AB0700 Successful experience with tocilizumab in two patients with macrophage activation syndrome associated with juvenile idiopathic arthritis |
| 003060 |
E. Fedorenko ; G. Lukina ; Y. Sigidin ; D. Karateev ; E. Luchikhina ; E. Nasonov [Russie] | AB0597 Comparative analysis of safety data of four treatment regimens in early rheumatoid arthritis patients |
| 003069 |
Y. Muraviev ; M. Podryadnova [Russie] ; E. Nasonov [Russie] | AB0588 Experience of tocilizumab using for resistant adult-onset still’s disease |
| 003078 |
T. Popkova [Russie] ; D. Novikova [Russie] ; E. Udachkina [Russie] ; E. Panasuk [Russie] ; A. Avdeeva [Russie] ; E. Alexandrova [Russie] ; A. Novikov [Russie] ; A. Volkov [Russie] ; E. Nasonov [Russie] | AB0578 Tocilizumab influence on the serum lipid profiles and rapid progression of intima media-thickness in patients with rheumatoid arthritis |
| 003102 |
M. Dubko [Russie] ; O. Kalashnikova [Russie] ; M. Kostik [Russie] ; L. Snegireva [Russie] | AB0554 Abatacept (ORENCIA): Experience of practical application |
| 003117 |
I. Guseva ; N. Soroka [Russie] ; A. Devyataykina ; G. Lukina ; E. Aleksandrova ; A. Novikov ; S. Glukhova ; D. Trofimov [Russie] ; E. Nasonov [Russie] | AB0538 TNFAIP3 RS675520 variant may predict response to rituximab treatment in rheumatoid arthritis |
| 003126 |
E. V. Tchetina ; K. H. Kuzikyants ; A. Y. Devyataikina ; G. V. Lukina ; E. L. Nasonov [Russie] | AB0529 Rituximab therapy monitoring by mtor, autophagy-related ULK1, caspase 3, CDK-inhibitor P21, TNF alpha, and osteoclast-specific cathepsin K and gelatinase MMP-9 gene expression in the peripheral blood of rheumatoid arthritis patients |
| 003131 |
E. Nasonov ; E. Panasyuk ; E. Shikina [Russie] ; T. Plaksina ; A. Dmitrieva ; L. Troegubova [Russie] | AB0525 Local open-label multicenter study to evaluate the quality of life in patients with moderate to severe active rheumatoid arthritis and an inadequate response to DMARDS when adding tocilizumab |
| 003149 |
A. S. Avdeeva ; E. N. Alexandrova ; E. Y. Panasyuk ; G. V. Lukina ; E. L. Nasonov [Russie] | AB0509 Comparative effectiveness of tocilizumab (TCZ) and rituximab (RTM) using different disease activity indices (DAS 28, SDAI and CDAI) in patients with rheumatoid arthritis (RA) |
| 003172 |
S. Lapshina [Russie] ; I. Akhtyamov [Russie] ; L. Myasoutova [Russie] | AB0360 Results of total hip prosthesis in patients with rheumatoid arthritis according to the received therapy |
| 003179 |
A. Roskidaylo [Russie] ; A. Logunov [Russie] ; S. Makarov [Russie] ; V. Amirdjanova [Russie] | AB0344 Total elbow replacement coonrad-morrey in patients with rheumatoid arthritis |
| 003180 |
A. Roskidaylo [Russie] ; M. Lipina [Russie] ; S. Makarov [Russie] ; M. Makarov [Russie] ; V. Amirdjanova [Russie] | AB0343 Arthroscopic synovectomy for the rheumatoid elbow (short-term outcome) |
| 003181 |
A. Rybnikov [Russie] ; E. Byalik [Russie] ; S. Makarov [Russie] ; V. Pavlov [Russie] ; T. Reshetnyak [Russie] ; M. Semenova [Russie] ; D. Ivanov [Russie] | AB0342 Prevention of venous thromboembolic complications in total hip and total knee arthroplasty for patients with rheumatic diseases |
| 003182 |
A. Alexeeva [Russie] ; Y. Mouraviev [Russie] ; E. Nasonov [Russie] | AB0341 Experience of tocilizumab usage in chronic renal insufficiency stipulated by aa-amyloidosis due to rheumatoid arthritis complication |
| 003211 |
I. R. Gaisin [Russie] ; L. V. Ivanova [Russie] | AB0313 Rituximab changes psychological attitudes to rheumatoid arthritis |
| 003216 |
E. Pogozheva ; V. Amirdzhanova ; S. Makarov [Russie] | AB0311 Postoperative complications in rheumatoid arthritis patients receiving rituximab and conventional disease-modifying antirheumatic drugs (dmards) |
| 003217 |
E. Panasyuk [Russie] ; E. Nasonov [Russie] | AB0310 Ra remission rates with tocilizumab therapy (lornet study: multicentre open-label, phase iv study of the quality of the life patient with severe/moderate ra with adding of tocilizumab to disease-modifying antirheumatic drugs therapy) |
| 003219 |
E. Filatova ; S. Erdes ; V. Alekseev [Russie] | AB0309 The impact of modern antirheumatic therapy on the neuropathic component of pain in patients with ra |
| 003225 |
E. V. Udachkina [Russie] ; D. S. Novikova [Russie] ; T. V. Popkova [Russie] ; A. S. Avdeeva [Russie] ; A. A. Novikov [Russie] ; E. N. Alexandrova [Russie] ; A. V. Volkov [Russie] ; E. L. Nasonov [Russie] | AB0306 Tocilizumab therapy resulted in significantly increased heart rate variability and improved lipid profile in patients with rheumatoid arthritis |
| 003234 |
A. S. Avdeeva [Russie] ; E. N. Alexandrova [Russie] ; A. V. Smirnov [Russie] ; A. A. Novikov [Russie] ; M. V. Cherkasova [Russie] ; E. Y. Panasyuk [Russie] ; E. L. Nasonov [Russie] | AB0299 Association of basal level antibodies to modified citrullinated vimentin (anti-mcv) with joint destruction in rheumatoid arthritis (ra) patients during the tocilizumab (tcz) therapy |
| 003263 |
A. S. Avdeeva ; E. N. Alexandrova ; A. A. Novikov ; E. Y. Panasyuk ; M. V. Cherkasova ; E. L. Nasonov [Russie] | AB0259 The high basal level antibodies to modified citrullinated vimentin (anti-MCV) – predictive factor of response to tocilizumab therapy in rheumatoid arthritis |
| 003264 |
T. A. Panafidina [Russie] ; L. V. Kondratyeva [Russie] ; E. V. Gerasimova [Russie] ; Y. N. Gorbunova [Russie] ; T. V. Popkova [Russie] ; E. L. Nasonov [Russie] | AB0259 Characteristics and cardiovascular comorbidities in patients with rheumatoid arthritis in a local patient cohort in russia |
| 003265 |
N. Shamsutdinova [Russie] ; S. Yakupova [Russie] ; A. Galimova [Russie] | AB0258 Patient with rheumatoid arthritis and strategy of treating rheumatoid arthritis to target |
| 003273 |
V. A. Malievsky ; T. V. Victorova [Russie] ; K. V. Danilko ; L. Nazarova | AB0253 The association of the IL1B and TNFα gene polymorphism with juvenile arthritis |
| 003275 |
A. Rebrov [Russie] ; M. Tyapkina [Russie] ; E. Voloshinova [Russie] | AB0204 Tubular dysfunction in patients with rheumatoid arthritis |
| 003280 |
Y. A. Ermakova [Russie] ; D. E. Karateev [Russie] ; E. L. Luchikhina [Russie] ; N. V. Demidova [Russie] ; E. L. Nasonov [Russie] | AB0199 Effect of the level of activity on functional status in patients with early rheumatoid arthritis (ra): results from the russion «radical» cohort during a 5-year follow-up. |
| 003582 |
P. Mease [États-Unis] ; V. Strand [États-Unis] ; L. Shalamberidze [Géorgie (pays)] ; A. Dimic [Serbie] ; T. Raskina [Russie] ; Li-An Xu [États-Unis] ; Y. Liu [États-Unis] ; J. Smith [États-Unis] | A phase II, double-blind, randomised, placebo-controlled study of BMS945429 (ALD518) in patients with rheumatoid arthritis with an inadequate response to methotrexate |
| 003648 |
Frantisek Drafi [Slovaquie] ; Katarina Bauerova [Slovaquie] ; Viera Kuncirova [Slovaquie] ; Silvester Ponist [Slovaquie] ; Danica Mihalova [Slovaquie] ; Tatiana Fedorova [Russie] ; Juraj Harmatha [République tchèque] ; Radomir Nosal [Slovaquie] | Pharmacological influence on processes of adjuvant arthritis: effect of the combination of an antioxidant active substance with methotrexate |
| 003976 |
Ewa Orlewska [Pologne] ; Ioan Ancuta [Roumanie] ; Branimir Anic [Croatie] ; Catalin Codrenau [Roumanie] ; Nemanja Damjanov [Serbie] ; Predrag Djukic [Serbie] ; Ruxandra Ionescu [Roumanie] ; Lubomir Marinchev [Bulgarie] ; Evgeny L. Nasonov [Russie] ; Tonu Peets [Estonie] ; Sonja Praprotnik [Slovénie] ; Rasho Rashkov [Bulgarie] ; Jana Skoupa [République tchèque] ; Witold Tlustochowicz [Pologne] ; Malgorzata Tlustochowicz [Pologne] ; Matija Tomsic [Slovénie] ; Tiina Veldi [Estonie] ; Jelena Vojinovic [Serbie] ; Piotr Wiland [Pologne] | Access to biologic treatment for rheumatoid arthritis in Central and Eastern European (CEE) countries |
| 003A08 |
Katerina Chatzidionysiou [Suède] ; Elisabeth Lie [Norvège] ; Evgeny Nasonov [Russie] ; Galina Lukina [Russie] ; Merete Lund Hetland [Danemark] ; Ulrik Tarp [Danemark] ; Cem Gabay ; Piet L C M. Van Riel [Pays-Bas] ; Dan C. Nordström [Finlande] ; Juan Gomez-Reino [Espagne] ; Karel Pavelka [République tchèque] ; Matija Tomsic [Slovénie] ; Tore K. Kvien [Norvège] ; Ronald F. Van Vollenhoven [Suède] | Highest clinical effectiveness of rituximab in autoantibody-positive patients with rheumatoid arthritis and in those for whom no more than one previous TNF antagonist has failed: pooled data from 10 European registries |
| 004149 |
Mark C. Genovese [États-Unis] ; James D. Mckay [États-Unis] ; Evgeny L. Nasonov [Russie] ; Eduardo F. Mysler [Argentine] ; Nilzio A. Da Silva [Brésil] ; Emma Alecock [Royaume-Uni] ; Thasia Woodworth [Royaume-Uni] ; Juan J. Gomez-Reino [Espagne] | Interleukin-6 Receptor Inhibition With Tocilizumab Reduces Disease Activity in Rheumatoid Arthritis With Inadequate Response to Disease-Modifying Antirheumatic Drugs : The Tocilizumab in Combination With Traditional Disease-Modifying Antirheumatic Drug Therapy Study |
| 004347 |
Mikhail M. Kostik [Oman] ; Eugenia A. Isupova [Russie] ; Irina A. Chikova [Russie] ; Margarita F. Dubko [Russie] ; Vera V. Masalova [Russie] ; Ludmila S. Snegireva [Russie] ; Olga V. Kalashnikova [Russie] ; Vyacheslav G. Chasnyk [Russie] | Reasons for inactive disease and flare in systemic onset juvenile idiopathic arthritis patients during tocilizumab treatment. |
